Sign in
Active, not recruitingNo phase

Registry of Patients With Acute/Subacute Type B Aortic Dissection Treated by Means of the STABILISE Technique (STABILISE)

Key facts

Who runs it
IRCCS San Raffaele
Where
Boston, Camden, Chapel Hill, Hartford, New York, Portland, Rochester, and Stanford, United StatesSee the 9 sitesAlso in 13 other countries, 25 sites
Trial code
Status
Active, not recruiting
People taking part
200 people, planned
Started
30 Oct 2018
Expected to end
30 Dec 2026
Type of study
Observational
Record updated
15 January 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Patients with ≥ 18 years of age
  • Patients presenting with an acute (up to two weeks from the onset) and subacute (between 3 and 12 weeks from the onset) type B dissection with a proximal suitable non-dissected landing zone in the aortic arch or descending thoracic aorta (supra-aortic trunks debranching may be employed to obtain an adequate proximal landing zone)
  • Total aortic diameter of the abdominal aorta (from supra-celiac to infra-renal level) must not exceed 42 mm
  • Patients able to sign specific informed consent for the study

Who cannot take part

  • Simultaneously participating in another investigative device or drug study
  • Surgical or endovascular AAA repair within 30 days before or after dissection repair
  • Previous placement of a thoracic endovascular graft
  • Prior open repair involving the descending thoracic aorta, including the supra-renal aorta and/or arch
  • Interventional and/or open surgical procedures (unrelated to dissection) within 30 days before or after dissection repair
  • Systemic infection (eg, sepsis)
  • Allergy to stainless steel, polyester, solder (tin, silver), polypropylene, nitinol, or gold
  • Patients with chronic type B aortic dissection (more than 12 weeks from the onset)
  • Patients with acute type B aortic dissection not treated according to the following treatment protocol
  • Unwilling or unable to comply with the follow-up schedule
  • Inability or refusal to give informed consent
  • Frank rupture
  • Untreatable reaction to contrast, which, in the opinion of the investigator, cannot be adequately premedicated

Where in United States

Also in 13 other countries, 25 sites

  • Beth Israel Deaconess Medical CenterBoston, United States
  • Cooper University Health CareCamden, United States
  • UNC HospitalsChapel Hill, United States
  • Hartford HospitalHartford, United States
  • Columbia University Irving Medical CenterNew York, United States
  • Knight Cardiovascular InstitutePortland, United States
  • Providence Heart and Vascular InstitutePortland, United States
  • Mayo ClinicRochester, United States
  • Falk Cardiovascular Research CenterStanford, United States

About the trial

What the trial wants to find out

The aim of the study is to evaluate results of patients treated with the STABILISE technique for acute/subacute aortic dissection. Results and postoperative events are reported in accordance with the current reporting standards for endovascular aortic repair prepared and revised by the Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/American Association for Vascular Surgery

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Physician-initiated, International, Multi-center, Prospective and Retrospective, Non Randomized, Observational Registry of Patients With Acute/Subacute Type B Aortic Dissection Treated by Means of the STABILISE Technique.
Record updated
15 January 2026